A Los Angeles jury has awarded $40 million to two women who claim Johnson & Johnson's talcum powder caused their ovarian ...

Johnson & Johnson's organic growth and margin expansion remain moderate. Read why I would not add fresh capital to JNJ stock ...

A California jury on Friday awarded $40 million to two women who said Johnson & Johnson’s baby powder was to blame for their ...

BofA raised Johnson & Johnson's price target to $220, citing steady growth, but sees limited upside from its pipeline through ...

FDA approves Johnson & Johnson's Akeega combo for BRCA2 metastatic prostate cancer after Phase 3 data showed major reductions ...

A Los Angeles jury ordered Johnson & Johnson to pay $966 million to the family of a woman who died from mesothelioma, finding the company liable in the latest trial alleging its talc products cause ...

A jury awarded $40 million to two women who claimed that talcum powder made by Johnson & Johnson caused their ovarian cancer.

Johnson & Johnson’s failed attempts to resolve a mountain of talcum powder lawsuits through class-action bankruptcy settlements have left the company with the daunting prospect of litigating cases ...

Johnson & Johnson was ordered to pay $966 million to the family of a woman who alleged the New Brunswick-headquartered health giant’s talcum-based baby powder gave her a fatal cancer. Following a ...

The New York Jets have agreed to a multi-year sponsorship with Johnson & Johnson to promote better health to Jets fans, making them the team's Official Medical Innovation Sponsor. Johnson & Johnson ...